Search

Your search keyword '"Wandt, H."' showing total 342 results

Search Constraints

Start Over You searched for: Author "Wandt, H." Remove constraint Author: "Wandt, H."
342 results on '"Wandt, H."'

Search Results

3. Long-term Follow Up of a Prospective Multicenter Trial with a High-Dose Cytosine Arabinoside and Daunorubicin Postremission Therapy in Adults with De Novo Acute Myeloid Leukemia

6. The 10.000/μl Morning Trigger for Prophylactic Platelet Transfusion is Safe: Prospective Experience in 411 AML Patients

10. The 10/NL Trigger for Prophylactic Platelet Transfusion in Acute Myeloid Leukemia: A Prospective Comparative Multicenter Study

12. Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up

15. The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)

27. Alternating courses of 3x CHOP and 3x DHAP plus Rituximab followed by a high dose ARA-C containing myeloablative regimen and autologous stem cell transplantation (ASCT) is superior to 6 courses CHOP plus Rituximab followed by myeloablative radiochemotherapy and ASCT in mantle cell lymphoma: Results of the MCL Younger Trial of the European mantle cell lymphoma network (MCL net): V116

36. Bortezomib, iv cyclophosphamide and dexamethasone (VCD) as induction therapy in newly diagnosed multiple myeloma: Update on the interim results with 300 patients of the German DSMM XIa trial: V333 - Best Abstract

37. Early allogeneic stem cell transplantation for peripheral T-cell lymphoma results in a lower relapse rate and a higher non-relapse mortality than high-dose therapy followed by autologous transplantation. Results of a retrospective EBMT analysis: O258

38. Dose-reduced conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis: results from a multicenter prospective trial of the chronic leukemia working party of the european group for blood and marrow transplantation (EBMT): 222

44. Prospective multicentre study of dose-reduced conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis. A study of the MDS subcommittee of the Chronic Leukaemia Working Party of the EBMT

45. Update of the registration study

49. Intensified conditioning therapy followed by a single auto-PBSCT versus tandem high-dose melphalan: preliminary analysis

50. Abstract

Catalog

Books, media, physical & digital resources